| dc.contributor.author | Lau, Allison N. |  | 
| dc.contributor.author | Vander Heiden, Matthew G. |  | 
| dc.date.accessioned | 2021-11-01T17:35:45Z |  | 
| dc.date.available | 2021-11-01T17:35:45Z |  | 
| dc.date.issued | 2020-03-09 |  | 
| dc.identifier.issn | 2472-3428 |  | 
| dc.identifier.issn | 2472-3428 |  | 
| dc.identifier.uri | https://hdl.handle.net/1721.1/136998 |  | 
| dc.description.abstract | <jats:p> Experiments in culture systems where one cell type is provided with abundant nutrients and oxygen have been used to inform much of our understanding of cancer metabolism. However, many differences have been observed between the metabolism of tumors and the metabolism of cancer cells grown in monoculture. These differences reflect, at least in part, the presence of nonmalignant cells in the tumor microenvironment and the interactions between those cells and cancer cells. However, less is known about how the metabolism of various tumor stromal cell types differs from that of cancer cells, and how this difference might inform therapeutic targeting of metabolic pathways. Emerging data have identified both cooperative and competitive relationships between different cell types in a tumor, and this review examines how four abundant stromal cell types in the tumor microenvironment, fibroblasts, T cells, macrophages, and endothelial cells, contribute to the metabolism of tumors. </jats:p> | en_US | 
| dc.language.iso | en |  | 
| dc.publisher | Annual Reviews | en_US | 
| dc.relation.isversionof | 10.1146/annurev-cancerbio-030419-033333 | en_US | 
| dc.rights | Creative Commons Attribution 4.0 International license | en_US | 
| dc.rights.uri | https://creativecommons.org/licenses/by/4.0/ | en_US | 
| dc.source | Annual Reviews | en_US | 
| dc.title | Metabolism in the Tumor Microenvironment | en_US | 
| dc.type | Article | en_US | 
| dc.identifier.citation | Lau, Allison N. and Vander Heiden, Matthew G. 2020. "Metabolism in the Tumor Microenvironment." 4 (1). |  | 
| dc.contributor.department | Koch Institute for Integrative Cancer Research at MIT |  | 
| dc.contributor.department | Massachusetts Institute of Technology. Department of Biology |  | 
| dc.eprint.version | Final published version | en_US | 
| dc.type.uri | http://purl.org/eprint/type/JournalArticle | en_US | 
| eprint.status | http://purl.org/eprint/status/PeerReviewed | en_US | 
| dc.date.updated | 2021-08-03T16:39:57Z |  | 
| dspace.orderedauthors | Lau, AN; Vander Heiden, MG | en_US | 
| dspace.date.submission | 2021-08-03T16:39:59Z |  | 
| mit.journal.volume | 4 | en_US | 
| mit.journal.issue | 1 | en_US | 
| mit.license | PUBLISHER_CC |  | 
| mit.metadata.status | Authority Work and Publication Information Needed | en_US |